05:49 PM EDT, 09/26/2024 (MT Newswires) -- EnVVeno Medical ( NVNO ) said Thursday it plans to sell common stock or pre-funded warrants through an underwritten public offering.

The company said it expects to grant underwriters a 30-day option to buy up to an additional 15% of shares and pre-funded warrants.

Net proceeds from the offering will be used for the development of its two lead products, VenoValve and enVVe, and general corporate purposes, according to the company.

Shares of EnVVeno fell nearly 15% in after-hours activity.

Price: 3.8400, Change: -0.66, Percent Change: -14.67